Theralase Technologies Inc. (TLT:TSXV) closed at $0.185 on November 13, 2026, unchanged on the day. The stock trades 54.9% below its 52-week high of $0.410 and 23.3% above its 52-week low of $0.150. Over the past year, it lost 11.9%. Theralase Technologies Inc. is part of the Life Sciences sector (Healthcare Facilities and Equipment).
In 252 trading sessions since November 13, 2025, TLT closed higher on 70 days (28%). Its best day was May 8, 2026 (+30.43%) and its worst was May 6, 2026 (-21.43%). The stock moved 10% or more in a single session 21 times. It opened at least 5% above the previous day's high 8 times.
Theralase Technologies Inc designs, develops, manufactures, markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain and also develops patented and patent pending drugs, called Photo Dynamic Compounds.
Find more stocks like TLT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.